Marilyn Bulloch, PharmD, BCPS

The only major change is in the included strain of influenza A/H2N2 virus, which has been updated for both the egg-based and the cell- and recombinant-based vaccines.

These drugs have interesting mechanisms, unique use, or may support expanded indications in the future.

Disease management is moving toward holistic care of the patient in the long term.

Pharmacists have the potential to make a positive impact by screening patients, providing counseling, encouraging beneficial interventions, and helping tailor patient regimens based on personalized needs.

While the exact reason for the decreased immune response in middle-aged adults remains unclear, these findings suggest that this patient population may be continuously susceptible to the 3c2A H3N2 infection, even with immunization.

Both strains of Influenza A for the northern hemisphere vaccines will be different from those included last season.

Support groups and patient care clinics have been created to help patients who suffer from lasting effects of the virus.

In 2018, the National Rosacea Society's focus will be around new classification standards.

With this year's strain of influenza gaining so much attention, due to its severity, it is important to understand and choose the best treatment option for any patient.

March is National Sleep Awareness Month, and pharmacists can help patients get their rest.

The Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) have released updated guidelines for Clostridium difficile infections.

A new study published in the Annals of Internal Medicine this week suggests that opioids may pose a different, unintended untoward consequence in patients: an increased risk of pneumococcal infection.

February is American Heart Month.

January is Thyroid Disorder Awareness Month, but the role of the pharmacist in managing this disorder can benefit the patient throughout the year.

Influenza season is in full swing and social media is buzzing about this product.

With the growth in pharmacy over the past 10 years, pharmacists are now at the forefront of managing many more disease states than in the past.

November is diabetes awareness month, and pharmacists are excellent resources for patients who have this chronic condition.

This year, the FDA is on pace to approve about 38 new medications. Here is a look at 6 of these.

This year, the FDA is on pace to approve about 38 new medications. Here is a look at 6 of these.

This year, the FDA is on pace to approve about 38 new medications. Here is a look at 4 of those.

This year, the FDA is on pace to approve about 38 new medications. Here is a look at 5 of those.

This year, the FDA is on pace to approve about 38 new medications. Here is a look at some new dermatology treatments.

Rivaroxaban with or without aspirin was evaluated for the secondary prevention of cardiovascular outcomes

In October, we celebrate American Pharmacists Month.

Pharmacists are in a prime position to help patients manage acute and chronic pain.

National Immunization Awareness Month (NIAM) is observed every August to bring attention the importance of vaccinating people of all ages.

Aspirin as we know it today is one of the cheapest and oldest painkillers on the market, but its therapeutic uses have expanded since it's development in the 19th century.

July is National Ultraviolet (UV) Awareness Month and the role of the pharmacist in sun safety is crucial.

The role of the pharmacist should be made known to our patients and the community.

The FDA approved betrixaban on June 23 as the first oral agent for the prevention of VTE prophylaxis in hospitalized medically ill adults